Medexus Pharmaceuticals Inc.
MEDXF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $2,247 | -$213 | $1,221 | -$2,879 |
| Dep. & Amort. | $7,178 | $5,806 | $6,081 | $6,145 |
| Deferred Tax | -$807 | $320 | -$6,262 | -$941 |
| Stock-Based Comp. | $411 | $469 | $1,216 | $1,883 |
| Change in WC | $5,843 | $2,341 | -$15,262 | $4,730 |
| Other Non-Cash | $9,162 | $9,991 | $11,562 | -$10,118 |
| Operating Cash Flow | $24,034 | $18,714 | -$1,444 | -$1,180 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$183 | -$50 | -$362 | -$7,714 |
| Net Acquisitions | -$3,275 | -$3,212 | -$1,359 | -$482 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$2,543 | -$216 | -$407 | -$9,523 |
| Investing Cash Flow | -$6,001 | -$3,478 | -$1,721 | -$8,196 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$14,236 | -$26,404 | $10,733 | $3,729 |
| Stock Issued | $19,162 | $7,606 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$4,130 | -$4,250 | -$4,328 | $947 |
| Financing Cash Flow | $796 | -$23,048 | $6,405 | $663 |
| Forex Effect | -$111 | -$2 | -$189 | $27 |
| Net Chg. in Cash | $18,718 | -$7,814 | $3,051 | -$8,686 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $5,255 | $13,069 | $10,018 | $18,704 |
| End Cash | $23,973 | $5,255 | $13,069 | $10,018 |
| Free Cash Flow | $21,308 | $18,448 | -$1,806 | -$8,894 |